|
ZNF460 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76980652355496E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.20140050422435E-10 |
| Normal-vs-Stage2 |
9.53770395994979E-11 |
| Normal-vs-Stage3 |
5.11510001022231E-09 |
| Normal-vs-Stage4 |
4.32210000012034E-07 |
| Stage1-vs-Stage2 |
5.816000E-03 |
| Stage1-vs-Stage3 |
2.278200E-01 |
| Stage1-vs-Stage4 |
5.624600E-01 |
| Stage2-vs-Stage3 |
1.826770E-01 |
| Stage2-vs-Stage4 |
1.832620E-01 |
| Stage3-vs-Stage4 |
7.545600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.07409686384608E-11 |
| Normal-vs-AfricanAmerican |
1.400240E-03 |
| Normal-vs-Asian |
2.00990000198686E-08 |
| Caucasian-vs-AfricanAmerican |
4.365000E-01 |
| Caucasian-vs-Asian |
2.019800E-01 |
| AfricanAmerican-vs-Asian |
9.897600E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59960000800652E-09 |
| Normal-vs-Female |
1.22729604257188E-11 |
| Male-vs-Female |
1.767620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.57040000003938E-07 |
| Normal-vs-Age(41-60Yrs) |
1.36668454331357E-12 |
| Normal-vs-Age(61-80Yrs) |
1.03389996564118E-09 |
| Normal-vs-Age(81-100Yrs) |
2.606400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.212500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.768990E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.145200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.709200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.538000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.819400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.663600E-02 |
| Classical-VS-Follicular |
9.738100E-02 |
| Classical-VS-Other |
9.700600E-01 |
| Classical-VS-Normal |
9.67219999647995E-08 |
| Tall-VS-Follicular |
7.809400E-01 |
| Tall-VS-Other |
3.294200E-01 |
| Tall-VS-Normal |
4.03790001435311E-09 |
| Follicular-VS-Other |
5.802200E-01 |
| Follicular-VS-Normal |
5.44279998848651E-09 |
| Other-VS-Normal |
2.974400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.97269986404558E-10 |
| Normal-vs-N1 |
1.53420000037485E-07 |
| N0-vs-N1 |
2.902400E-01 |
|
|
